-
Something wrong with this record ?
Ibuprofen does not impair skeletal muscle regeneration upon cardiotoxin-induced injury
S. Dalle, C. Poffé, C. Hiroux, F. Suhr, L. Deldicque, K. Koppo
Language English Country Czech Republic
Document type Journal Article
NLK
Directory of Open Access Journals
from 1991
Free Medical Journals
from 1998
PubMed Central
from 2020
ProQuest Central
from 2005-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1998
- MeSH
- Anti-Inflammatory Agents, Non-Steroidal pharmacology MeSH
- Wound Healing drug effects physiology MeSH
- Ibuprofen pharmacology MeSH
- Cardiotoxins toxicity MeSH
- Muscle, Skeletal drug effects injuries pathology physiology MeSH
- Disease Models, Animal MeSH
- Mice, Inbred C57BL MeSH
- Mice MeSH
- Regeneration drug effects MeSH
- Signal Transduction drug effects MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Muscle regeneration is regulated through interaction between muscle and immune cells. Studies showed that treatment with supra-physiological doses of Non-Steroidal Anti-Inflammatory Drug (NSAID) abolished inflammatory signaling and impaired muscle recovery. The present study examines the effects of pharmacologically-relevant NSAID treatment on muscle regeneration. C57BL/6 mice were injected in the tibialis anterior (TA) with either PBS or cardiotoxin (CTX). CTX-injected mice received ibuprofen (CTX-IBU) or were untreated (CTX-PLAC). After 2 days, Il-1beta and Il-6 expression was upregulated in the TA of CTX-IBU and CTX-PL vs. PBS. However, Cox-2 expression and macrophage infiltration were higher in CTX-PL vs. PBS, but not in CTX-IBU. At the same time, anabolic markers were higher in CTX-IBU vs. PBS, but not in CTX-PL. Nevertheless, ibuprofen did not affect muscle mass or muscle fiber regeneration. In conclusion, mild ibuprofen doses did not worsen muscle regeneration. There were even signs of a transient improvement in anabolic signaling and attenuation of inflammatory signaling.
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21028130
- 003
- CZ-PrNML
- 005
- 20211129135922.0
- 007
- ta
- 008
- 211105s2020 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.934482 $2 doi
- 035 __
- $a (PubMed)32901495
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Dalle, S. $u Exercise Physiology Research Group, Department of Movement Sciences, Catholic University of Leuven, Leuven, Belgium
- 245 10
- $a Ibuprofen does not impair skeletal muscle regeneration upon cardiotoxin-induced injury / $c S. Dalle, C. Poffé, C. Hiroux, F. Suhr, L. Deldicque, K. Koppo
- 504 __
- $a Literatura
- 520 9_
- $a Muscle regeneration is regulated through interaction between muscle and immune cells. Studies showed that treatment with supra-physiological doses of Non-Steroidal Anti-Inflammatory Drug (NSAID) abolished inflammatory signaling and impaired muscle recovery. The present study examines the effects of pharmacologically-relevant NSAID treatment on muscle regeneration. C57BL/6 mice were injected in the tibialis anterior (TA) with either PBS or cardiotoxin (CTX). CTX-injected mice received ibuprofen (CTX-IBU) or were untreated (CTX-PLAC). After 2 days, Il-1beta and Il-6 expression was upregulated in the TA of CTX-IBU and CTX-PL vs. PBS. However, Cox-2 expression and macrophage infiltration were higher in CTX-PL vs. PBS, but not in CTX-IBU. At the same time, anabolic markers were higher in CTX-IBU vs. PBS, but not in CTX-PL. Nevertheless, ibuprofen did not affect muscle mass or muscle fiber regeneration. In conclusion, mild ibuprofen doses did not worsen muscle regeneration. There were even signs of a transient improvement in anabolic signaling and attenuation of inflammatory signaling.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antiflogistika nesteroidní $x farmakologie $7 D000894
- 650 _2
- $a kardiotoxiny $x toxicita $7 D054715
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a ibuprofen $x farmakologie $7 D007052
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední C57BL $7 D008810
- 650 _2
- $a kosterní svaly $x účinky léků $x zranění $x patologie $x fyziologie $7 D018482
- 650 _2
- $a regenerace $x účinky léků $7 D012038
- 650 _2
- $a signální transdukce $x účinky léků $7 D015398
- 650 _2
- $a hojení ran $x účinky léků $x fyziologie $7 D014945
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Poffé, C. $u Exercise Physiology Research Group, Department of Movement Sciences, Catholic University of Leuven, Leuven, Belgium
- 700 1_
- $a Hiroux, C. $u Exercise Physiology Research Group, Department of Movement Sciences, Catholic University of Leuven, Leuven, Belgium
- 700 1_
- $a Suhr, F. $u Exercise Physiology Research Group, Department of Movement Sciences, Catholic University of Leuven, Leuven, Belgium
- 700 1_
- $a Deldicque, L. $u Institute of Neuroscience, Université Catholique de Louvain, Louvainla-Neuve, Belgium
- 700 1_
- $a Koppo, K. $u Exercise Physiology Research Group, Department of Movement Sciences, Catholic University of Leuven, Leuven, Belgium
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 69, č. 5 (2020), s. 847-859
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32901495 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y p $z 0
- 990 __
- $a 20211105 $b ABA008
- 991 __
- $a 20211122163829 $b ABA008
- 999 __
- $a ok $b bmc $g 1728739 $s 1148675
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 69 $c 5 $d 847-859 $e 20200909 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $b NLK118 $a Pubmed-20211105